Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03499841
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
3MN![]() | 3-({3-[3-(1H-IMIDAZOL-1-YL)PROPYL]- 5-METHYL-5-(1-NAPHTHYL)-2,4-DIOXOIMIDAZOLIDIN- 1-YL}METHYL)BENZONITRILE | B | 2F0Y | 0.73 | ![]() |
FR6![]() | 1-{(1R,2S)-2-HYDROXY-1-[2-(1-NAPHTHYL)ETHYL]PROPYL}- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 2E1W | 0.72 | ![]() |
FTH![]() | 1-[2-(4-CYANO-BENZYLAMINO)-3-(3- METHYL-3H-IMIDAZOL-4-YL)-PROPIONYL]- 5-NAPHTHALEN-1-YL-1,2,3,6-TETRAHYDRO- PYRIDINE-4-CARBONITRILE | B | 1N95 | 0.71 | ![]() |
FR3![]() | 1-((1R)-1-(HYDROXYMETHYL)-3-(1- NAPHTHYL)PROPYL)-1H-IMIDAZOLE-4- CARBOXAMIDE | A | 1NDY | 0.72 | ![]() |
REM![]() | Nalpha-[(2S)-2-benzyl-3-(tert-butylsulfonyl)propanoyl]- N-[(1S,2R,3S)-1-(cyclohexylmethyl)- 3-cyclopropyl-2,3-dihydroxypropyl]- L-histidinamide | A,B | 3D91 | 0.72 | ![]() |
TMI![]() | 1-[PHENYL-(4-PHENYLPHENYL)-METHYL]IMIDAZOLE | A | 2BDM | 0.7 | ![]() |
1BN![]() | 1-BENZYL-1H-IMIDAZOLE | A,B | 2AFX | 0.71 | ![]() |
HBN![]() | N-(2-NAPHTHYL)HISTIDINAMIDE | B | 1VEA | 0.71 | ![]() |
CX1![]() | N-[(benzyloxy)carbonyl]-L-histidyl- N-methyl-L-phenylalanyl-L-tyrosine | B | 3C72 | 0.74 | ![]() |
IM1![]() | B | 1BDQ | 0.8 | ![]() | |
IM1![]() | A,B | 1TCW | 0.8 | ![]() | |
IM1![]() | A | 1SBG | 0.8 | ![]() | |
IM1![]() | A,B | 1BDL | 0.8 | ![]() | |
IM1![]() | B | 1BDR | 0.8 | ![]() | |
IM1![]() | A | 1TCX | 0.8 | ![]() | |
XX5![]() | (S,S)-2-{1-CARBOXY-2-[3-(3,5-DICHLORO- BENZYL)-3H-IMIDAZOL-4-YL]-ETHYLAMINO}- 4-METHYL-PENTANOIC ACID | A | 1R4L | 0.74 | ![]() |
FR2![]() | 1-((1R)-1-(HYDROXYMETHYL)-3-PHENYLPROPYL)- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1NDW | 0.76 | ![]() |
C60![]() | [[[3-(2-METHYL-PROPANE-2-SULFONYL)- 1-BENZENYL]-2-PROPYL]-CARBONYL- HISTIDYL]-AMINO-[CYCLOHEXYLMETHYL]- [2-HYDROXY-4-ISOPROPYL]-PENTAN- 5-OIC ACID BUTYLAMIDE | A | 1RNE | 0.71 | ![]() |
IH4![]() | N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2- PHENYLETHYL) | A | 2BJU | 0.79 | ![]() |
WRG![]() | N~2~-acetyl-N~5~-[N-(methylcarbamoyl)carbamimidoyl]- L-ornithyl-N-methyl-L-phenylalanine | A,B | 3CHD | 0.7 | ![]() |
MIM![]() | [CYCLOHEXYLETHYL]-[[[[4-[2-METHYL- 1-IMIDAZOLYL-BUTYL]PHENYL]ACETYL]- SERYL]-LYSINYL]-AMINE | A | 2NMT | 0.83 | ![]() |
MIM![]() | [CYCLOHEXYLETHYL]-[[[[4-[2-METHYL- 1-IMIDAZOLYL-BUTYL]PHENYL]ACETYL]- SERYL]-LYSINYL]-AMINE | A,B | 1IYK | 0.83 | ![]() |
224![]() | 1-({2-[2-(4-CHLOROPHENYL)ETHYL]- 1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE | A | 2DY5 | 0.73 | ![]() |
LEH![]() | N-[12-(1H-imidazol-1-yl)dodecanoyl]- L-leucine | A,B | 3BEN | 0.7 | ![]() |
VGB![]() | (5R,6R,7R,8S)-6,7-dihydroxy-5-(hydroxymethyl)- 2-(2-phenylethyl)-8-(propanoylamino)- 5,6,7,8-tetrahydro-1H-imidazo[1,2- a]pyridin-4-ium | A,B | 2WB5 | 0.72 | ![]() |
RC7![]() | {(2R)-4-(4-HYDROXYBENZYL)-2-[2- (1H-IMIDAZOL-4-YL)ETHYL]-5-OXO- 2,5-DIHYDRO-1H-IMIDAZOL-1-YL}ACETALDEHYDE | A,B,C,D | 2GW4 | 0.75 | ![]() |
GSZ![]() | N-[(5R,6R,7R,8S)-6,7-DIHYDROXY- 5-(HYDROXYMETHYL)-2-(2-PHENYLETHYL)- 1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2- A]PYRIDIN-8-YL]-2-METHYLPROPANAMIDE | A,B | 2J62 | 0.72 | ![]() |